Abstract: Disclosed are .beta.-lactams of formula I ##STR1## wherein X is a chromogenic or fluorogenic substituted aryl or heteroaryl, which are specific inhibitors of Human leukocyte elastase (HLE). Upon contact with HLE these compounds are cleaved to form a chromogenic or fluorogenic species which may be readily measured by the assay disclosed herein. The assay thus provides a means for direct measurement of the amount of active HLE in a body fluid or other sample.
Type:
Grant
Filed:
January 3, 1992
Date of Patent:
July 20, 1993
Assignee:
Merck & Co., Inc.
Inventors:
Wilson B. Knight, William K. Hagmann, Alan L. Maycock
Abstract: A new antibiotic having .beta.-lactamase inhibitory activity, PA-31088-IV, being useful as a medicament and a veterinary drug for inhibiting the growth of gram-positive and gram-negative phathogenic microorganisms and a process for preparing the same, being characterized by cultivating Streptomyces tokunonensis sp. nov. in a suitable medium and recovering PA-31088-IV from the cultured broth.
Abstract: Bis-ethynyl quinoxaline compositions are prepared by the condensation reaction of an aromatic diglyoxyl or dibenzil with an ethynyl-substituted aromatic ortho-diamine. The compositions are useful as polymerizable plasticizers for heterocyclic thermoplastic resins in the fabrication of composites. Polymerizable plasticizers are materials that remain fluid and act as a plasticizer during early stages of fabrication and then polymerize to a rigid resin.
Type:
Grant
Filed:
December 23, 1976
Date of Patent:
April 25, 1978
Assignee:
The United States of America as represented by the Secretary of the Air Force
© 2025 Justia
